Purified E. histolytica amylases III to VI were characterized by their hydrolytic behaviour towards 4-nitrophenyl a-malto-oligosaccharides, malto-oligosaccharides, amylose, amylopectin, glycogen and Y-cyclodextrin. The influence of specific inhibitors on the amylase activity of E. histolytica was examined and compared with typical a-and ß-amylases.Amylases III and IV showed -glucosidase and glucosyltransferase activity by cleaving terminal non-reducing glucose from pNPGj (III, IV) and pNPG 2 to pNPG 7 (III). Both enzymes were able to cleave malto-oligosaccharides and glucopolysaccharides to a large number of malto-oligosaccharides. Also transglucosidation reactions were observed, but maltose was not hydrolysed. Amylase V showed exoamylase-like properties by preferentially cleaving maltose units from the non-reducing end of synthetic and biogenic malto-oligosaccharides by a multiple-attack mechanism. Amylase VI was characterized as an -amylase, showing great similarities with porcine pancreatic -amylase in the hydrolysis pattern of 4-nitrophenyl a-malto-oligosaccharides and glucopolysaccharides. With biogenic malto-oligosaccharides amylase VI showed a transglucosidation reaction.
Trennung und Charakterisierung von vier Amy lasen aus Entamoeba histolytica. II. Charakterisierung der Amy lasenZusammenfassung: Gereinigte Amylasen III bis VI aus Entamoeba histolytica wurden aufgrund ihres hydrolytischen Verhalten gegenüber 4-Nitrophenyl-a-maltooligosacchariden, Maltooligosacchariden, Amylose, Amylopektin, Glycogen and Y-Cyclodextrin charakterisiert. Der Einfluß spezifischer Inhibitoren auf die Amylaseaktivität aus E. histolytica wurde untersucht und mit
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.